Mayo researchers find that an investigational oral drug combo shows promise for newly diagnosed multiple myeloma

The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma. …read more

Source:: Cancer